Eintrag weiter verarbeiten
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
Gespeichert in:
Zeitschriftentitel: | British Journal of Haematology |
---|---|
Personen und Körperschaften: | , , , , , , , , , , |
In: | British Journal of Haematology, 159, 2012, 1, S. 82-87 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
Zusammenfassung: | <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p> |
---|---|
Umfang: | 82-87 |
ISSN: |
0007-1048
1365-2141 |
DOI: | 10.1111/j.1365-2141.2012.09239.x |